Weight Loss
GLP-1 and ADHD: Emerging Research on Impulse Control & Weight
People with ADHD are 40 to 70% more likely to be obese than people without it. The reasons are tangled.
GLP-1 and Addiction: How Weight Loss Drugs May Curb Substance Use
The first stories were anecdotal.
Exenatide Real Results: Weight Loss Timeline and What Patients Report
Exenatide produces real but modest results compared with newer GLP-1 drugs.
The Endocrine System and Weight: How Hormones Control Everything
If body weight were just calories in and calories out, weight loss would be a math problem. It is not.
Efinopegdutide Real Results: Weight Loss Timeline & What Patients Report
Introduction Efinopegdutide’s main published efficacy data comes from the Romero-Gomez 2023 Journal of Hepatology phase 2a trial: 145 adults with MASH-related liver fat (MRI-PDFF…
The Economics of Obesity: Why GLP-1 Medications Pay for Themselves
Obesity is expensive. The CDC estimates the annual medical cost of obesity in the United States at over $173 billion in 2019 dollars.
Dulaglutide Real Results: Weight Loss Timeline & What Patients Report
Dulaglutide is approved for type 2 diabetes and cardiovascular protection in diabetes patients with established CVD.
Stress, Cortisol & Weight: Breaking the Cycle with GLP-1
The cortisol-belly-fat story has been butchered by wellness Instagram into a supplement pitch.
CagriSema Real Results: Weight Loss Timeline & What Patients Report
CagriSema’s REDEFINE 1 phase 3 trial showed mean weight loss of about 22.7% at 68 weeks.
